NIH-funded research R21 grant

Investigating neurons derived from olfactory cells to understand schizophrenia

Official title: Olfactory neuroepithelial cell derived induced neurons for study of schizophrenia

Funded at Thomas Jefferson University · NIH-10747189 · Data updated 2026-11-12

This study is exploring a new way to turn special cells from the nose into brain cells that can help us understand schizophrenia better, which could lead to new insights about the condition and how it affects people.

More Schizophrenia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$475,813
NIH project number1R21MH132097-01A1
Project IDNIH-10747189 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia or those with a family history of the disorder.

Less likely to help

Patients without a diagnosis of schizophrenia or related psychiatric disorders may not benefit from this research.

What this research studies

This research focuses on developing a new method to create neurons directly from olfactory neuroepithelial cells, which may better reflect the genetic and epigenetic characteristics of individuals with schizophrenia. By bypassing the stem cell stage, these directly-converted induced neurons (DCiNs) aim to provide a more accurate model for studying the neurobiological aspects of schizophrenia. The project will assess how well these neurons can replicate the complex features of the illness, potentially leading to better insights into its pathophysiology.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for schizophrenia.

How similar studies have gone: While the use of induced neurons for studying psychiatric disorders is gaining traction, this specific approach using olfactory neuroepithelial cells is relatively novel and has not been extensively tested.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hahn, Chang-Gyu — Thomas Jefferson University
  • Study coordinator: Hahn, Chang-Gyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.